Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Open-market sale Chief Scientific Officer sold 19,351 shares at an average $8.80 ($170,289)
  2. 4 Open-market sale President and CEO sold 9,741 shares at $8.67 ($84,454)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale President and CEO sold 19,473 shares at an average $8.93 ($173,991)
  6. 4 Open-market sale Chief Scientific Officer sold 9,665 shares at $11.08 ($107,088)
  7. 4 Open-market sale Chief Scientific Officer sold 19,326 shares at an average $11.44 ($221,184)
  8. 4 Open-market sale President and CEO sold 9,712 shares at $11.36 ($110,328)
  9. 4 Open-market sale President and CEO sold 19,421 shares at an average $11.58 ($224,992)
  10. 4 Open-market sale Chief Scientific Officer sold 9,660 shares at $12.04 ($116,306)
  11. 4 Open-market sale Chief Scientific Officer sold 16,534 shares at an average $11.82 ($195,434)
  12. 4 Open-market sale President and CEO sold 9,705 shares at $12.23 ($118,692)
  13. 4 Open-market sale President and CEO sold 19,402 shares at an average $12.79 ($248,148)
  14. 4 Open-market sale Chief Scientific Officer sold 6,444 shares at $12.25 ($78,939)
  15. 4 Open-market sale Chief Scientific Officer sold 13,492 shares at an average $11.82 ($159,455)
  16. 4 Open-market sale President and CEO sold 9,697 shares at $13.37 ($129,649)
  17. 4 Open-market sale President and CEO sold 19,913 shares at an average $13.63 ($271,459)
  18. 4 Open-market sale Chief Operating Officer sold 10,000 shares at $16.49 ($164,900)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 11 of 14 · 269 filings